Maternal Micronutrients May Shape Child Growth and Blood Pressure

    Maternal nutrition during pregnancy plays a critical role in shaping fetal development and may have lasting effects on a child’s long-term health. Emerging research suggests that beyond supporting birth outcomes, prenatal micronutrient intake may influence growth, cardiovascular development, and even blood pressure later in life.

    One study examined whether maternal nutrition during pregnancy can influence offspring blood pressure in adolescence (1). Researchers followed adolescents from two rural counties in western China whose mothers had participated in a cluster-randomized prenatal supplementation trial. Pregnant women at less than 28 weeks of gestation were randomly assigned to receive one of three daily supplements: folic acid (400 µg), iron plus folic acid (60 mg iron as ferrous sulfate and 400 µg folic acid), or multiple micronutrients (MMNs) using the UNIMMAP formulation. The MMN supplement included 30 mg iron, 400 µg folic acid, 65.0 µg selenium, 15.0 mg zinc, 150.0 µg iodine, 2.0 mg copper, 800.0 µg vitamin A, 1.4 mg vitamin B1 (thiamine), 1.4 mg vitamin B2 (riboflavin), 1.9 mg vitamin B6, 2.6 µg vitamin B12, 70.0 mg vitamin C, 5.0 µg vitamin D, 10.0 mg vitamin E, and 18.0 mg niacin, taken daily until delivery (1).

    At follow-up, blood pressure was measured using a validated electronic device and converted into standardized percentiles. Among 4,488 eligible singleton births, 1,994 adolescents (44.4%) were followed up, with a mean age of 11.73 years and 59.2% male. After adjusting for potential confounders, adolescents whose mothers received MMNs had slightly lower systolic blood pressure (−1.13 mmHg) and lower blood pressure percentiles (−2.59 points) compared to those whose mothers received folic acid alone. They also had a reduced likelihood of elevated blood pressure (defined as ≥95th percentile for age, sex, and height) (1).

    A separate randomized controlled trial in Nepal evaluated the effects of maternal micronutrient supplementation on child growth and early health outcomes (2). In this study, 1,200 pregnant women were randomized to receive either iron (60 mg) and folic acid (400 μg) or a multiple micronutrient supplement containing 15 vitamins and minerals during the second and third trimesters. The MMN formulation included vitamin A (800 μg), vitamin E (10 mg), vitamin D (5 μg), vitamin B1 (1.4 mg), vitamin B2 (1.4 mg), niacin (18 mg), vitamin B6 (1.9 mg), vitamin B12 (2.6 μg), folic acid (400 μg), vitamin C (70 mg), iron (30 mg), zinc (15 mg), copper (2 mg), selenium (65 μg), and iodine (150 μg) (2).

    Follow-up of their children at 2–3 years of age included 917 participants (455 control, 462 intervention), assessed at a mean age of 2.5 years. Mean birthweight had been 77 g higher (95% CI: 24–130 g) in the micronutrient group. At 2.5 years, children in the control group weighed a mean of 10.7 kg (SD 1.38), compared to 10.9 kg (SD 1.54) in the intervention group. Overall, children whose mothers received MMNs were on average 204 g heavier (95% CI: 27–381 g) than controls (2).

    In addition to weight, children in the intervention group had slightly greater measurements in head circumference (+2.4 mm), chest circumference (+3.2 mm), mid-upper arm circumference (+2.4 mm), and triceps skinfold thickness (+2.0 mm). Systolic blood pressure was also modestly lower by 2.5 mmHg in the micronutrient group (2).

    The link between prenatal MMN supplementation and lower blood pressure is likely driven by several overlapping biological mechanisms. Adequate micronutrient intake during pregnancy supports fetal cardiovascular development, including blood vessel formation and regulatory systems involved in blood pressure control. Nutrients such as folate, iron, zinc, and vitamins C and E contribute to nitric oxide production and antioxidant defense, supporting endothelial function.

    Micronutrients also help reduce oxidative stress during pregnancy, protecting fetal vascular development. In addition, nutrients involved in one-carbon metabolism (such as folate and B vitamins) play a role in epigenetic programming, influencing how genes related to blood pressure regulation are expressed over time. Kidney development is another key factor, as nephron number is largely determined before birth and is associated with long-term blood pressure regulation.

Overall, these findings highlight the important role of maternal nutrition during pregnancy in shaping a child’s long-term health. Even modest improvements in early growth and small reductions in blood pressure suggest that the prenatal environment can influence how a child’s body develops and functions years later. Ensuring adequate intake of a broad range of essential micronutrients during pregnancy may therefore serve as an early, foundational strategy to support healthier growth and reduce future cardiovascular risk in the next generation.

References:

1. Feng H, Li X, Shan J, Zhu Y, Wang L, Huang L, Wang X, Jingele X, Yan J, Liu Y, Li S, Nan L, Cheng Y, Zeng L, Zhu Z. Associations of antenatal micronutrient supplementation with adolescent blood pressure: evidence from a 14-year follow-up study of a randomized controlled trial. BMC Public Health. 2025 Nov 22;25(1):4421. doi: 10.1186/s12889-025-25672-y. PMID: 41275168; PMCID: PMC12754940.

2. Vaidya A, Saville N, Shrestha BP, Costello AM, Manandhar DS, Osrin D. Effects of antenatal multiple micronutrient supplementation on children's weight and size at 2 years of age in Nepal: follow-up of a double-blind randomised controlled trial. Lancet. 2008 Feb 9;371(9611):492-9. doi: 10.1016/S0140-6736(08)60172-5. PMID: 18262041; PMCID: PMC2241662.

   
   

Image created by ChatGPT